Medical research

Could an antibody drug help you shed pounds?

An experimental antibody drug that targets one of the body's key metabolism regulators may help obese people lose weight—at least briefly.

Diseases, Conditions, Syndromes

Even mild fatty liver disease is linked to increased mortality

Non-alcoholic fatty liver disease, NAFLD, affects nearly one in four adults in Europe and the U.S. Earlier research has demonstrated an increased risk of death in patients with NAFLD and advanced fibrosis or cirrhosis. Now, ...

Health

How protein protects against fatty liver

Non-alcoholic fatty liver disease is the most common chronic liver disease in the world, with sometimes life-threatening consequences. A high-protein, calorie-reduced diet can cause the harmful liver fat to melt away—more ...

Diseases, Conditions, Syndromes

Osteopontin, a protein not always as bad as it is made out to be

Metabolic fatty liver disease, known as non-alcoholic fatty liver disease, is one of the most common causes of liver disease in Western countries and covers a spectrum of disorders. It is strongly associated with metabolic ...

page 27 from 40